Myeloma Minue IMF

[annie]

Welcome to the IMF's Myeloma Minute
News about myeloma treatment, research, support and the myeloma community
14/02/21012
from the International Myeloma Foundation.
WHAT'S NEWS

FDA Approves Subcutaneous Administration of VELCADE® In All Approved Indications
physicians treating patients with poor vein access or who have peripheral neuropathy and those at high risk of developing it now have another weapon in their armamentarium against myeloma.
http://myeloma.org/ArticlePage.action?t ... exPageId=1

New IMWG Guidelines on Management of treatment-emergent peripheral neuropathy in multiple myeloma
These guidelines represent a capsule summary of the new IMWG paper Management of treatment-emergent peripheral neuropathy in multiple myeloma published in Leukemia.
http://myeloma.org/ArticlePage.action?t ... PageId=284

New International Working Group Paper on Maintenance Therapy
http://myeloma.org/pdfs/Blood-2012-Ludwig.pdf
Maintaining results of successful induction therapy is an important goal in multiple myeloma. In this paper published in Blood, members of the International Myeloma Working Group review the relevant data.

IMPORTANT NEW SURVEY ON THE WEB
http://imf-fish.questionpro.com/
The purpose of this short survey is to determine the underlying reasons for the increased risk of myeloma in certain races and in family members, as well as to understand whether the subtypes of myeloma occur more commonly in one group over the other. This study will provide important information that will help all patients with myeloma. You do not need to reveal any identifying information to participate in this study.

Member FUNdraisers Support Research Grants
http://myeloma.org/IndexPage.action?tab ... goryId=187
In December of 2011, seven Brian D. Novis Research Grants were presented at the grant reception at ASH, six of which were funded by our member fundraising program. Junior Grants are funded at $50,000 and Senior Grants are funded at $80,000. Some of the funds for these grants were raised from one event, and others from cumulative smaller annual events. Donors can see first-hand the results of all their hard work in putting together their fundraisers, whether it's a garage sale or a golf tournament – no event is too small. If you are interested in starting a program to raise money for research, please contact Suzanne Battaglia at sbattaglia@myeloma.org or by phone at (800) 452-2873. She can help you with ideas and offer support and materials to help make your event or campaign a success.
Using Your Own Body to Attack Cancer
http://www.dailyrx.com/news-article/mul ... 17208.html
Immunotherapy rResearch for multiple myeloma has been difficult because the cancer cells can be very different from each other. In a recent presentation to the 53rd annual meeting of the American Society of Hematology, scientists at the Dana Farber Cancer Institute said they now believe they have solved this problem, and they're ready to find out in human trials. (from dailyRx)

Less May Be More in Treating High-Risk Myeloma
http://www.oncologyreport.com/news/clin ... acd21.html
"While the limitations of this retrospective study limit drawing definitive conclusions, it appears that poor cytogenetics and biology trump treatment intensification," Dr. Rachid Baz and his colleagues stated in a poster presentation at the annual meeting of the American Society of Hematology. (from The Oncology Report)

Last Chance to Participate in Myeloma 200. Win a Dream Vacation to Costa Rica!
https://online.myeloma.org/netcommunity/myeloma200
Help the IMF reach its goal of $200,000 for our Research, Education, Support and Advocacy Programs by participating in Myeloma 200 - Closer to a Cure! and be entered into a drawing for a trip for two for 7 days and 6 nights to the beautiful Four Seasons Costa Rica, including airfare and a $400 gift certificate toward spa treatments.
https://online.myeloma.org/netcommunity/myeloma200

Abrazos